Cystic fibrosis lung disease: interplay of a microbial microcosm and extremes of inflammation.
Blau
Hannah
H
Department of Pediatrics, Schneider Children's Medical Center, Petah Tiqva, Israel.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D019005:Cystic Fibrosis Transmembrane Conductance Regulator